LibrarianMeg said:NicoleRaleigh said: ...we don't know the long-term effects of cardiovascular risk...
CRP reduction on cardiovascular risk — this is the lab result that excites me most:
Baseline hsCRP: 12.0 mg/L (high cardiovascular risk)
Month 6 hsCRP: 2.5 mg/L (moderate risk)
Month 12 hsCRP: 0.4 mg/L (low risk)
This level of inflammatory marker reduction is comparable to what you'd see with statin therapy. Combined with the weight loss, my 10-year ASCVD risk score dropped from 19% to 5%. My cardiologist is genuinely impressed.
Following on from LibrarianMeg — and this may be the naive question:
How long did you give it before you decided it was working?
TrialTracker_MD said:CRP reduction on cardiovascular risk — this is the lab result that excites me most: Baseline hsCRP: 12.0 mg/L (high cardiovascular risk) Month 6…
Cardiac biomarkers and cardiovascular risk: my cardiologist ordered advanced cardiac labs given my family history. Results were encouraging:
- NT-proBNP: 54 pg/mL (normal, cardiac function preserved)
- Lp(a): 34 nmol/L (genetic, unchanged — expected)
- ApoB: dropped from 149 to 94 mg/dL (excellent response)
- Coronary calcium score: 0 (unchanged from baseline — reassuring)
The ApoB reduction is particularly meaningful — it's considered the best single predictor of cardiovascular risk. GLP-1 therapy seems to improve this consistently.
PeptideDetective — Independent Peptide Analytics
Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.
View ResultsTrialTracker_MD said:CRP reduction on cardiovascular risk — this is the lab result that excites me most: Baseline hsCRP: 12.0 mg/L (high cardiovascular risk) Month 6…
Lp(a) and cardiovascular risk: a nuance that matters. Unlike most lipid markers, Lp(a) is 90%+ genetically determined and doesn't really change with weight loss or GLP-1 therapy.
My Lp(a) has remained at 84 nmol/L across all time points. If yours is elevated (>50 nmol/L), you need additional risk mitigation strategies regardless of your GLP-1 response. Don't assume your medication is covering all cardiovascular risk factors.
BethLabQueen said:Cardiac biomarkers and cardiovascular risk: my cardiologist ordered advanced cardiac labs given my family history.
Senior perspective on cardiovascular risk: I'm 64 years old and started this journey skeptically. My cardiologist recommended it after years of failed interventions.
14 months later: down 42 lbs, more mobile, pain reduced, medications simplified. My quality of life has improved dramatically. I wish this existed 20 years ago.
To other older adults hesitating: the SELECT trial proved benefit in our age group. You deserve to feel good in your body regardless of age.